442 related articles for article (PubMed ID: 10539883)
1. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
Favaloro EJ; Facey D; Henniker A
Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies.
Favaloro EJ; Kershaw G; Bukuya M; Hertzberg M; Koutts J
Haemophilia; 2001 Mar; 7(2):180-9. PubMed ID: 11260278
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
[TBL] [Abstract][Full Text] [Related]
5. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
[TBL] [Abstract][Full Text] [Related]
6. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
[TBL] [Abstract][Full Text] [Related]
7. Utility of the platelet function analyser (PFA-100/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making.
Favaloro EJ
Thromb Res; 2020 Apr; 188():17-24. PubMed ID: 32036157
[TBL] [Abstract][Full Text] [Related]
8. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.
Cattaneo M; Federici AB; Lecchi A; Agati B; Lombardi R; Stabile F; Bucciarelli P
Thromb Haemost; 1999 Jul; 82(1):35-9. PubMed ID: 10456451
[TBL] [Abstract][Full Text] [Related]
10. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
[TBL] [Abstract][Full Text] [Related]
11. Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.
Pekrul I; Kragh T; Turecek PL; Novack AR; Ott HW; Spannagl M
Platelets; 2019; 30(2):264-270. PubMed ID: 29319374
[TBL] [Abstract][Full Text] [Related]
12. The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von willebrand concentrate in type III von willebrand disease.
Meskal A; Vertessen F; Van der Planken M; Berneman ZN
Ann Hematol; 1999 Sep; 78(9):426-30. PubMed ID: 10525831
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates.
Fressinaud E; Veyradier A; Sigaud M; Boyer-Neumann C; Le Boterff C; Meyer D
Br J Haematol; 1999 Sep; 106(3):777-83. PubMed ID: 10468873
[TBL] [Abstract][Full Text] [Related]
14. Laboratory characterization of obligate carriers of type 3 von Willebrand disease with a potential role for Platelet Function Analyzer (PFA-200).
Geevar T; Dave RG; Mathews NS; Kumar S; Mammen JJ; Vijayan R; Aboobacker FN; Abraham A; Srivastava A; Nair SC
Int J Lab Hematol; 2022 Jun; 44(3):603-609. PubMed ID: 34986515
[TBL] [Abstract][Full Text] [Related]
15. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease].
Schlammadinger A; Kerényi A; Muszbek L; Boda Z
Orv Hetil; 2000 Oct; 141(41):2245-50. PubMed ID: 11184249
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.
Nummi V; Lassila R; Joutsi-Korhonen L; Armstrong E; Szanto T
Int J Lab Hematol; 2018 Jun; 40(3):304-311. PubMed ID: 29427305
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency.
Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B
Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
19. Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia.
Naik S; Teruya J; Dietrich JE; Jariwala P; Soundar E; Venkateswaran L
Pediatr Blood Cancer; 2013 Jul; 60(7):1184-7. PubMed ID: 23335259
[TBL] [Abstract][Full Text] [Related]
20. Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey.
Favaloro EJ; Thom J; Baker R;
Blood Coagul Fibrinolysis; 2000 Dec; 11(8):729-37. PubMed ID: 11132651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
